Tag: big pharma

Urgent health warning as the terrifying side effects of Ozempic emerge

Dozens of Aussie weight loss drug injection patients have complained of symptoms consistent with drug-induced hepatitis, sparking a warning from experts to get regular GP check-ups. 

Patients on GLP-1 agonists Wegovy and Ozempic reported flu-like symptoms, fatigue, abdominal cramps and vomiting, thought to be related to liver injury. 

The most severe cases were rushed to hospital after experiencing symptoms associated with inflammation of the liver. 

The Therapeutic Goods Administration (TGA) has received three separate reports of hepatitis or liver injury associated with semaglutide medicine use – marketed as Ozempic and Wegovy. 

Two patients were on Ozempic while the other was using Wegovy. 

Patients on Mounjaro have also expressed concerns online.

‘Any of you on Mounjaro have had to stop taking it due to it affecting your liver? I’m currently in hospital with medication induced hepatitis and they’re positive it’s from the Mounjaro,’ one woman wrote.

Another commented: ‘Wegovy badly affected my liver and I had to stop, fortunately I didn’t end up in hospital’. 

Keep reading

President Trump Pardons Former Governor Rowland – Did Big Pharma Target Him for His Psychiatric Drug Ban?

Recently Pardoned Former Governor John Rowland’s political downfall is often reduced to scandalous headlines about gifts and corruption, but the truth behind his resignation reveals a far more complex and troubling story—one that involves a fierce battle with Big Pharma, a controversial psychiatric drug ban for vulnerable children, and a corruption scandal that may not be as disconnected as it seems.

In the early 2000s, Governor Rowland took a rare and bold stand against the wrongful medication of children in state care by banning three powerful antipsychotic drugs from Connecticut’s drug formulary: Risperdal (risperidone), Zyprexa (olanzapine), and Seroquel (quetiapine). These medications were widely prescribed despite mounting evidence of severe side effects, including increased risks of suicide, diabetes, and violent behavior. The ban thrust Connecticut into the national spotlight when The New York Times ran a front-page article in 2004 exposing the widespread use—and potential dangers—of these psychiatric drugs in children under state supervision, sparking a nationwide conversation about the ethics and safety of medicating vulnerable youth.

That same year, National Public Radio (NPR) also covered Connecticut’s groundbreaking actions, highlighting the state’s efforts to protect children from inappropriate psychiatric drug use and the challenges faced in regulating these medications. The NPR coverage emphasized the growing concern over the off-label use of antipsychotics in children, the lack of adequate oversight, and the pushback from pharmaceutical companies.

Connecticut’s legislative and regulatory bodies responded with a six-month review of psychotropic medication use in children in state care, resulting in public acts aimed at establishing oversight mechanisms and protecting children from inappropriate drug use. This review was part of a broader effort to address systemic issues such as lack of informed consent and insufficient court approvals.

Across the country, states like New York, Florida, New Jersey, and Arkansas also made national news for confronting the rampant and often off-label use of antipsychotic medications in children in foster care. Investigations and lawsuits against pharmaceutical companies such as Johnson & Johnson and Eli Lilly highlighted illegal marketing practices promoting these drugs for unapproved uses in children. Connecticut emerged as one of the front lines in this battle, with state legislators and child welfare agencies scrutinizing psychotropic drug use and seeking greater oversight and protections for children in care.

Rowland’s ban challenged powerful pharmaceutical interests. According to advocacy groups like AbleChild, representatives from Canadian pharmaceutical companies met with the governor behind closed doors, pressing him to reverse the decision. Within six months, the banned drugs were reinstated on the state formulary, raising urgent questions about the influence of Big Pharma on public health policy and the safety of children in care.

Keep reading

New WHO Guidance Calls for Injectable Contraceptives for Kids

The World Health Organization (WHO) released a new guideline on preventing adolescent pregnancies in low and middle-income countries. The proposed framework advances a vision of sexual and reproductive health and rights (SRHR) for young people that promotes controversial ideas, and norm changes inconsistent with what governments have agreed to.

Revised for the first time in over a decade, the guideline focuses almost exclusively on preventing adolescent pregnancies through increased and prolonged contraception use, including “self-administered injectable contraception,” and access to sexuality education.

In its recommendations, the WHO frames adolescents’ choice to discontinue “contraceptive use due to side-effects, and due to changing life circumstances and reproductive intentions” in a negative light and as an obstacle to overcome.

The framework calls on mobilizing “[p]olitical, governmental, religious, traditional and other influential leaders” to “support the access to, uptake of, and continued use of contraceptives.”

The guideline also asks policymakers to ensure that laws on age and consent related to sexual activities are designed in such a way as to promote adolescents’ access to contraception. Such a move could mean lowering the age of legal consent or making regulations more flexible to enable young people’s access to contraception without stigma.

Critics note that an exclusive focus on mass contraceptive use among adolescents monopolizes the discourse on how to best prevent adolescent pregnancies and undermines efforts to tackle the problem holistically.

The 112-page guideline does not mention the merits of raising awareness about the negative consequences of nonmarital sexual behavior through programs centered around abstinence and delay of sexual debut.

Critics also disagree with the WHO framing adolescents’ opposition to contraceptives due to side effects or religious beliefs as based on myths and misinformation.

Beyond its recommendations on contraceptives, the guideline promotes adolescents’ access to sex education, saying that “[m]any adolescents are unaware…[on how] to have sex safely and pleasurably.”

The document references the latest UN inter-agency technical guidance on comprehensive sexuality education (CSE), which has helped shape sexuality education curricula and materials in many countries around the world.

The technical guidance dedicates an entire section to the “Social Construction of Gender and Gender Norms,” teaching children aged 5-8 the difference between biological sex and gender and encouraging them to “reflect on how they feel about their biological sex and gender.” The same section says children aged 9-12 should be able to “explain how someone’s gender identity may not match their biological sex” and “acknowledge that masturbation does not cause physical or emotional harm.”

Another goal laid out in the CSE guidance is that children aged 12- 15 are able to state that sexual “fantasies and desires are natural and not shameful and occur throughout life.”

Keep reading

China’s Groundbreaking Diabetes Breakthrough—And the Global Backlash

In a revelation that could transform global healthcare, Chinese scientists have reportedly developed a stem cell therapy that reverses both Type 1 and Type 2 diabetes. While this scientific leap offers new hope for over 500 million people worldwide living with the chronic disease, it also threatens to shake up the multi-billion-dollar pharmaceutical industry that thrives on treating—not curing—diabetes.

At the core of this innovation is a technique that uses a patient’s own fat cells to generate insulin-producing islet cells. These engineered cells are then transplanted into the body, where they naturally regulate blood sugar levels. Since the cells are autologous (derived from the same person), there’s no risk of immune rejection, and patients don’t require immunosuppressants.

Initial trials have produced jaw-dropping results:

  • A 25-year-old woman with Type 1 diabetes went off insulin completely within 75 days.
  • A 59-year-old man with Type 2 diabetes was insulin-free in just 11 weeks. One year later, he remains off all medication.

This therapy takes advantage of induced pluripotent stem cell (iPSC) technology, a method of reprogramming adult cells to behave like embryonic stem cells. Scientists then coax these cells into becoming islet cells, which the pancreas uses to produce insulin.

The process essentially rebuilds a diabetic pancreas from the inside out—without the need for donor organs, immune-suppressing drugs, or lifelong insulin therapy.

Keep reading

$67 In France And $798 In US – Why Prescription Drug Prices Are So High In America

Prescription drugs cost more in the United States than anywhere else in the world. President Donald Trump and some bipartisan senators want to change that.

Trump has so far issued several actions related to prescription drug prices. The latest, announced May 12, is a Most Favored Nation Prescription Drug policy, requiring pharmaceutical companies to offer their lowest price to U.S. customers.

An earlier order aimed to ensure that the middlemen in the drug supply chain can’t hold on to rebates provided by pharmaceutical companies and instead must pass savings on to Medicare beneficiaries.

In all, the president has taken at least a dozen actions to reduce prescription drug costs, while no less than nine Senate bills aim for the same results.

Some of these ideas have been introduced before.

Trump’s Most Favored Nation pricing plan was introduced near the end of his first term.

The plan was stalled by court challenges, and President Joe Biden dropped it shortly after taking office.

A plan to make vendors pass manufacturer discounts on to Medicare beneficiaries was proposed in 2020. Biden rescinded it before it took effect.

There have been modest successes, including a pilot program begun by Trump in 2020 to cap insulin costs for Medicare Part B beneficiaries at $35 per month. At the time, a single vial of insulin cost about $100 in the United States.

That program was a success, and the idea was later broadened to include all Medicare beneficiaries through the Inflation Reduction Act of 2022. By 2024, most major drug companies had voluntarily limited out-of-pocket expenses for insulin for all U.S. customers to $35.

Yet Americans still pay nearly three times as much for prescription medication as any peer nation, often even more.

Trulicity, a medication for Type 2 diabetics, was listed for $67 in France, according to a 2021 Government Accountability Report. In the United States, it cost $798.

Meanwhile, Remlivid, an oral cancer medication, was listed for $4,723 in Australia. In the United States, it was listed at almost five times that price: $22,048.

Keep reading

FDA Forces Moderna and Pfizer to Admit Covid “Vaccines” Cause Lasting Heart Damage in Young Males

For years, parents and medical professionals have sounded the alarm about the dangerous link between mRNA COVID-19 vaccines and heart inflammation in young males—only to be dismissed as “anti-vaxxers” or conspiracy theorists. Now, in a stunning reversal, the U.S. Food and Drug Administration (FDA) has ordered Pfizer and Moderna to strengthen their warning labels, finally admitting that these shots can cause long-lasting heart damage, particularly in adolescent boys and young men.

But this admission comes far too late—after millions of doses were administered under false pretenses, after countless young lives were altered by myocarditis, and after public health agencies actively suppressed the truth. The FDA’s belated action raises a critical question: How many more injuries could have been prevented if the government had prioritized transparency over blind vaccine promotion?

Key points:

  • The FDA has mandated that Pfizer and Moderna update their COVID-19 vaccine labels to include stronger warnings about myocarditis and pericarditis, particularly in males aged 16 to 25.
  • New data reveals that myocardial injury is often long-lasting, contradicting earlier CDC claims that heart inflammation “tends to resolve quickly.”
  • The highest incidence of myocarditis occurs in young males, with 38 cases per million doses—far higher than previously acknowledged.
  • Internal government emails show that health officials deliberately avoided warning the public about these risks, even after detecting safety signals in 2021.
  • The FDA’s action follows a Senate investigation exposing how federal agencies downplayed and hid vaccine injuries.

A long-overdue admission of harm

For years, independent researchers and medical professionals warned that mRNA vaccines posed a disproportionate risk to young, healthy individuals—especially males. Yet, public health agencies dismissed these concerns, insisting that the benefits outweighed the risks. Now, the FDA has been forced to acknowledge what health freedom fighters have said all along: These vaccines can cause serious, sometimes permanent, heart damage.

The updated labels must now state that myocardial injury is common among those who develop post-vaccination myocarditis, with data showing persistent damage five months after vaccination. This directly contradicts the CDC’s previous assurances that cases were “mild” and “resolved quickly.”

Why did it take so long? Internal documents obtained through FOIA requests reveal that as early as May 2021, the CDC and FDA considered issuing a public warning but ultimately chose silence over transparency.

The suppression of truth and the cost of deception

The Senate’s Permanent Subcommittee on Investigations recently released a damning report exposing how federal health agencies systematically concealed the myocarditis risk linked to COVID-19 vaccines. Internal emails reveal that officials engaged in a coordinated cover-up by refusing to update the V-safe reporting system to include cardiac symptoms, ensuring countless cases were never documented. Additionally, they blocked a planned Health Alert Network warning that would have alerted doctors and the public to the dangers, prioritizing public perception over transparency.

Keep reading

Lawmakers Move To Protect Your DNA After 23andMe Bankruptcy

Regeneron Pharmaceuticals was named the winning bidder in the court-supervised sale of 23andMe, granting it eventual access to a gigantic pool of genetic data from an estimated 15 million individuals. The deal has raised alarm bells in Washington, DC, prompting bipartisan lawmakers to introduce a bill that would strengthen protections for genetic data during bankruptcy proceedings. 

Fox News has learned that Republican Senators John Cornyn and Chuck Grassley, along with Democratic Senator Amy Klobuchar, are preparing to introduce the Don’t Sell My DNA Act, a bipartisan measure to protect consumers’ sensitive genetic data. The bill comes just days after renewed privacy concerns surrounding 23andMe.  

Keep reading

Jim Jordan probes politics of Pfizer COVID vax trial as research suggests jabs hurt fertility

The political pressures around clinical trials for COVID-19 vaccines in the 2020 presidential campaign first drew scrutiny from Democrats, with then-nominees Joe Biden and Kamala Harris spreading mistrust of Operation Warp Speed and suggesting they would avoid jabs developed in the Trump administration.

The parties largely switched sides in the Biden administration, with then-Vice President Harris claiming it was “starting from scratch” on a vaccine strategy and even mandating vaccinations for her own campaign employees once she replaced Biden at the top of the 2024 ticket.

Yet Republicans have continued claiming Operation Warp Speed saved millions of lives based on modeling studies, amid five years of global research on severe adverse events in certain groups following COVID vaccination, from heart inflammation to neurological disorders, and the jabs’ mediocre-to-negative performance against infection.

House Judiciary Committee GOP leaders seized on new evidence Thursday that Pfizer withheld what it considered positive trial results until after the 2020 election, with the result that President Trump couldn’t take credit for a finished vaccine, giving Republicans something to unite around amid internal divisions over the pace of reversing Biden’s COVID vaccine policies.

The Department of Health and Human Services is reportedly planning to stop recommending routine COVID vaccines for pregnant women, teens and children, more than 100 days into the Trump administration and after new peer-reviewed research suggests COVID vaccines worsen fertility and mRNA jabs specifically can produce spike protein for up to eight months.

Yet another peer-reviewed study this year, published in the Endocrine Society’s Journal of Clinical Endocrinology and Metabolism, found the risk of underactive thyroid “significantly increased from 6 to 12 months” after vaccination, and that both under- and overactive thyroid was “significantly elevated at 12 months” for mRNA vaccine recipients specifically.

The Taiwanese researchers “used a huge database, carefully matched vaccinated and unvaccinated patients, and followed outcomes for a full year,” former New York Times drug industry reporter Alex Berenson wrote. “That combination gave the study very strong statistical power, meaning that its findings are probably not the result of chance.”

“25,000 children a day are getting the latest version of the mRNA shot,” Texas doctor Mary Talley Bowden, an early victim of COVID treatment policing whose litigation prompted the FDA to stop demonizing ivermectin on social media, wrote on X Friday.

Keep reading

Pfizer’s election meddling exposed: Top scientists weaponized science to sway the 2020 vote, so they could benefit from unlawful mandates

In the high-stakes world of corporate power and political manipulation, few revelations strike as deeply as the allegation that Pfizer executives deliberately slowed COVID-19 vaccine trials to influence the 2020 U.S. election. Newly uncovered testimony suggests that top Pfizer R&D leaders orchestrated a delay in clinical testing—not for scientific caution, but to ensure results wouldn’t emerge before Election Day. This bombshell, revealed through congressional investigations, paints a damning picture of a pharmaceutical giant willing to play god with public health for political and financial gain. The implications are staggering: a company entrusted with saving lives instead weaponized its science, suppressed critical data, and helped shape an election that led to unprecedented medical coercion.

Key points:

  • Congressional investigators allege Pfizer intentionally slowed vaccine trials to avoid influencing the 2020 election.
  • Former Pfizer scientist Dr. Philip Dormitzer reportedly admitted the delay was orchestrated by senior R&D leaders.
  • The timing allowed Pfizer to avoid scrutiny before the election, then rapidly deploy mandates under a new administration.
  • The scheme backfired as vaccine failures and injuries mounted, exposing the fraud behind the rushed approvals.
  • The investigation raises urgent questions about corporate collusion, government corruption, and the erosion of medical ethics.

The election interference playbook

The 2020 presidential race was already one of the most contentious in U.S. history, with COVID-19 lockdowns, mask mandates, and promises of a “miracle” vaccine dominating the national conversation. Internal documents and whistleblower testimony now suggest Pfizer executives saw an opportunity—not to serve public health, but to exploit it. According to GSK’s testimony to Congress, Dr. Philip Dormitzer, a former Pfizer R&D leader, revealed that the company’s top three scientists deliberately slowed trial progress to avoid releasing data before November.

Dr. Dormitzer had told GSK employees that “in late 2020, the three most senior people in Pfizer R&D were involved in a decision to deliberately slow down clinical testing so that it would not be complete prior to the results of the presidential election that year.”

This wasn’t about scientific rigor—it was about political timing. Had Pfizer released results in October, then-President Donald Trump could have claimed credit for Operation Warp Speed, potentially swaying voters eager for an end to pandemic restrictions. Instead, Pfizer’s calculated delay left the public in limbo, fueling frustration and anger that Democrats weaponized against Trump. By the time the vaccine was unveiled under the Biden administration, the groundwork had been laid for aggressive mandates, despite mounting evidence of the shot’s inefficacy and risks.

Keep reading

FDA Says It Plans to Remove Some Fluoride Drugs for Children From Market

The Food and Drug Administration (FDA) plans to remove ingestible prescription drugs for children that contain fluoride, the agency announced on May 13.

The ingestible products have been linked to issues such as a disrupted gut microbiome.

“The best way to prevent cavities in children is by avoiding excessive sugar intake and good dental hygiene, not by altering a child’s microbiome. For the same reason that fluoride may kill bacteria on teeth, it may also kill intestinal bacteria important for a child’s health,” Dr. Marty Makary, commissioner of the FDA, said in a statement.

Researchers reported in a review article in March that multiple studies have found that the gut microbiota was negatively impacted in people who ingested high amounts of fluoride, a disruption that can lead to problems such as cancer.

The FDA said it plans to complete a safety review by Oct. 31 before “taking appropriate action regarding removal of these products from the market.” At the same time, its parent agency, the Department of Health and Human Services, is planning to provide the public with guidance on strong dental hygiene for children that does not alter gut health.

“Ending the use of ingestible fluoride is long overdue,” Health Secretary Robert F. Kennedy Jr. said in a statement. “I’m grateful to Commissioner Makary for his leadership on this vital issue—one that directly safeguards the health and development of our children.”

Keep reading